| New insights into atopic dermatitis DYM Leung, M Boguniewicz, MD Howell, I Nomura, QA Hamid The Journal of clinical investigation 113 (5), 651-657, 2004 | 2100 | 2004 |
| Cytokine modulation of atopic dermatitis filaggrin skin expression MD Howell, BE Kim, P Gao, AV Grant, M Boguniewicz, A DeBenedetto, ... Journal of Allergy and Clinical Immunology 124 (3), R7-R12, 2009 | 1477 | 2009 |
| Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes I Nomura, E Goleva, MD Howell, QA Hamid, PY Ong, CF Hall, MA Darst, ... The Journal of Immunology 171 (6), 3262-3269, 2003 | 966 | 2003 |
| Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6 BE Kim, DYM Leung, M Boguniewicz, MD Howell Clinical immunology 126 (3), 332-337, 2008 | 613 | 2008 |
| IL-31 is associated with cutaneous lymphocyte antigen–positive skin homing T cells in patients with atopic dermatitis J Bilsborough, DYM Leung, M Maurer, M Howell, M Boguniewcz, L Yao, ... Journal of Allergy and Clinical Immunology 117 (2), 418-425, 2006 | 451 | 2006 |
| Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb A Wollenberg, MD Howell, E Guttman-Yassky, JI Silverberg, C Kell, ... Journal of Allergy and Clinical Immunology 143 (1), 135-141, 2019 | 419 | 2019 |
| Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus MD Howell, RL Gallo, M Boguniewicz, JF Jones, C Wong, JE Streib, ... Immunity 24 (3), 341-348, 2006 | 387 | 2006 |
| Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum MD Howell, JF Jones, KO Kisich, JE Streib, RL Gallo, DYM Leung The Journal of Immunology 172 (3), 1763-1767, 2004 | 377 | 2004 |
| Cathelicidin deficiency predisposes to eczema herpeticum MD Howell, A Wollenberg, RL Gallo, M Flaig, JE Streib, C Wong, T Pavicic, ... Journal of Allergy and Clinical Immunology 117 (4), 836-841, 2006 | 359 | 2006 |
| Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities MH Braff, MA Hawkins, AD Nardo, B Lopez-Garcia, MD Howell, C Wong, ... The Journal of Immunology 174 (7), 4271-4278, 2005 | 358 | 2005 |
| The promise of digital health: then, now, and the future A Abernethy, L Adams, M Barrett, C Bechtel, P Brennan, A Butte, ... NAM perspectives 2022, 10.31478/202206e, 2022 | 286 | 2022 |
| T cell repertoire following autologous stem cell transplantation for multiple sclerosis PA Muraro, H Robins, S Malhotra, M Howell, D Phippard, C Desmarais, ... The Journal of clinical investigation 124 (3), 1168-1172, 2014 | 284 | 2014 |
| Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial M Jagasia, MA Perales, MA Schroeder, H Ali, NN Shah, YB Chen, S Fazal, ... Blood, The Journal of the American Society of Hematology 135 (20), 1739-1749, 2020 | 269 | 2020 |
| Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation MD Howell, HR Fairchild, BE Kim, L Bin, M Boguniewicz, JS Redzic, ... Journal of Investigative Dermatology 128 (9), 2248-2258, 2008 | 258 | 2008 |
| Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis MD Howell, N Novak, T Bieber, S Pastore, G Girolomoni, M Boguniewicz, ... Journal of investigative dermatology 125 (4), 738-745, 2005 | 254 | 2005 |
| Mechanism of HBD-3 deficiency in atopic dermatitis MD Howell, M Boguniewicz, S Pastore, N Novak, T Bieber, G Girolomoni, ... Clinical immunology 121 (3), 332-338, 2006 | 252 | 2006 |
| IL-4 and IL-13 negatively regulate TNF-α-and IFN-γ-induced β-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3 C Albanesi, HR Fairchild, S Madonna, C Scarponi, O De Pita, DYM Leung, ... The Journal of Immunology 179 (2), 984-992, 2007 | 247 | 2007 |
| TNF-α downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-α antagonists to improve skin barrier BE Kim, MD Howell, E Guttman, PM Gilleaudeau, IR Cardinale, ... Journal of Investigative Dermatology 131 (6), 1272-1279, 2011 | 239 | 2011 |
| Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial D Rosmarin, AG Pandya, M Lebwohl, P Grimes, I Hamzavi, AB Gottlieb, ... The Lancet 396 (10244), 110-120, 2020 | 230 | 2020 |
| Targeting the Janus kinase family in autoimmune skin diseases MD Howell, FI Kuo, PA Smith Frontiers in immunology 10, 2342, 2019 | 218 | 2019 |